ACPP polyclonal, anti-human, mouse, rat
€388.00
In stock
SKU
BS6510
Background:
Human prostatic acid phosphatase (also known as PAcP, PAP, PPAP, ACPP) is a prostate epithelium-specific differentiation antigen. The cellular form of PAcP functions as a neutral protein-tyrosine phosphatase, and is involved in regulating prostate cell growth. Specifically, PAcP catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. PAcP is synthesized under androgen regulation. The stimulated secretion of prostatic acid phosphatase is a hallmark of androgen action on human prostate epithelial cells, implicating PAcP as a useful tool in identifying atrophy of prostatic tissue. Cellular PAcP can down-regulate prostate cancer cell growth, at least partially by dephosphorylating c-ErbB-2/neu. Therefore, decreased cellular PAcP expression in cancer cells may be involved in prostate cancer progression. PAcP is the protein product of the human ACPP gene, which maps to chromosome 3q21-q23.
Alternative Name:
5'-NT, 5'-nucleotidase, Acid phosphatase prostate, ACP 3, ACP3, ACPP, Ecto-5'-nucleotidase, PAP, PPAP, Prostatic acid phosphatase, Prostatic acid phosphotase, Thiamine monophosphatase, TMPase,
Application Dilution: WB: 1:500 - 1:2000, IF: 1:50 - 1:200
Specificity: ACPP polyclonal antibody detects endogenous levels of ACPP protein.
Immunogen:
Recombinant full length Human ACPP.
MW: ~ 45 kDa
Swis Prot.: P15309
Purification & Purity:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Format:
1mg/ml in PBS with 0.1% Sodium Azide, 50% Glycerol.
Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For research use only, not for use in diagnostic procedure.
Human prostatic acid phosphatase (also known as PAcP, PAP, PPAP, ACPP) is a prostate epithelium-specific differentiation antigen. The cellular form of PAcP functions as a neutral protein-tyrosine phosphatase, and is involved in regulating prostate cell growth. Specifically, PAcP catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. PAcP is synthesized under androgen regulation. The stimulated secretion of prostatic acid phosphatase is a hallmark of androgen action on human prostate epithelial cells, implicating PAcP as a useful tool in identifying atrophy of prostatic tissue. Cellular PAcP can down-regulate prostate cancer cell growth, at least partially by dephosphorylating c-ErbB-2/neu. Therefore, decreased cellular PAcP expression in cancer cells may be involved in prostate cancer progression. PAcP is the protein product of the human ACPP gene, which maps to chromosome 3q21-q23.
Alternative Name:
5'-NT, 5'-nucleotidase, Acid phosphatase prostate, ACP 3, ACP3, ACPP, Ecto-5'-nucleotidase, PAP, PPAP, Prostatic acid phosphatase, Prostatic acid phosphotase, Thiamine monophosphatase, TMPase,
Application Dilution: WB: 1:500 - 1:2000, IF: 1:50 - 1:200
Specificity: ACPP polyclonal antibody detects endogenous levels of ACPP protein.
Immunogen:
Recombinant full length Human ACPP.
MW: ~ 45 kDa
Swis Prot.: P15309
Purification & Purity:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Format:
1mg/ml in PBS with 0.1% Sodium Azide, 50% Glycerol.
Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For research use only, not for use in diagnostic procedure.
| Is Featured? | No |
|---|
Write Your Own Review